Study tracking outcomes in Moyamoya disease
Part of Brain & nervous system, Heart & circulation, Mental health clinical trials.
This study looks at how Moyamoya disease changes over time and what predicts outcomes. It uses approved brain imaging and, likely, thinking/memory tests to understand prognosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Moyamoya disease confirmed by angiography or brain MRI
- Your age is over 10 and under 60
- You can read/understand enough to do study materials (at least primary school education)
- You must be willing to sign the informed consent form
- You do not have major/large stroke, many small stroke areas, or severely enlarged hydrocephalus after brain bleeding
- You should be able to do cognitive (thinking) tests and complete all scheduled MRI scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people with moyamoya disease have trouble with thinking and memory. It may help find better ways to understand and treat these problems.
This trial follows people with moyamoya disease who are treated with medication only, and it also looks at first-degree relatives. The goal is to understand long-term outcomes and whether careful conservative care is beneficial over time.
This study is building a tool to predict how people with moyamoya disease will do after brain surgery to improve blood flow. If you are an adult with moyamoya and are scheduled for this surgery, you may be able to help.
This study investigates moyamoya disease, a rare condition where blood vessels in the brain narrow over time. Researchers want to identify genetic and early warning signs by studying people diagnosed with the disease, their blood relatives, and healthy volunteers.
This study uses advanced MRI scans to better predict the risk of bleeding in people with moyamoya disease, a rare condition where brain arteries narrow. It aims to improve prevention of bleeding strokes.
This study tests if statins (cholesterol-lowering drugs) can help people with Moyamoya disease. The trial will follow patients who receive either surgery or standard care to see if adding a statin improves outcomes.
Hear when a new Moyamoya Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.